Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone have?
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone has 2 citations in the OpenAlex counts ScholarIQ stores.
When was Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone published?
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone has 2026 year in the ScholarIQ index.
What is the open-access status of Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone?
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone has hybrid oa status in the ScholarIQ index.
What is the DOI of Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone?
The DOI for Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone is on the source record.
What is the PMID of Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone?
The PMID for Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone is on the source record.
What is the OpenAlex record for Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone?
The OpenAlex for Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone is on the source record.